Endemic nosocomial Acinetobacter calcoaceticus bacteremia. Clinical significance, treatment, and prognosis
- 1 December 1985
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 145 (12), 2174-2179
- https://doi.org/10.1001/archinte.145.12.2174
Abstract
The medical records of 27 patients with blood cultures positive for Acinetobacter calcoaceticus over a recent fiveyear period (0.7% of all positive blood cultures) were reviewed retrospectively to determine the epidemiologic and clinical significance of these isolates. Eighteen isolates represented true bacteremias, 16 of which were hospital acquired. Patients most frequently were located in an intensive care unit or on a surgical ward. A seasonal July-to-September peak incidence was noted. The most common site of primary infection was the respiratory tract. Aminoglycosides, alone or in combination with a second agent, were used to treat all but one infection. Bacteriologic cure was achieved in 15 cases (88%); six patients had polymicrobial sepsis that carried a higher mortality than pure A calcoaceticus bacteremia (50% vs 0%). Acinetobacter, a low-virulence opportunistic pathogen, may be an infrequent but potentially serious endemic agent of nosocomial bacteremia in some institutions. The prognosis of bacteremia, when appropriately treated, appears to be good. (Arch Intern Med 1985;145:2174-2179)This publication has 5 references indexed in Scilit:
- The New Beta-Lactamase-Stable CephalosporinsAnnals of Internal Medicine, 1982
- Pyrogenic Reactions After Inadvertent Infusion of Endotoxin During Cardiac CatheterizationsAnnals of Internal Medicine, 1980
- Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilliAntimicrobial Agents and Chemotherapy, 1980
- Polymicrobial BacteremiaAnnals of Internal Medicine, 1970
- Infection of Man with MimeaeAnnals of Internal Medicine, 1963